These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27978775)

  • 1. Can AMH levels predict the need for increased medication during IVF/ICSI in PCOS women?
    Kamel A; Ramadan W; Hussein AM; Dahab S; Elsherbini MM; Lasheen YS; Abu-Hamila F
    J Matern Fetal Neonatal Med; 2018 Jan; 31(1):32-38. PubMed ID: 27978775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.
    Amer SA; Mahran A; Abdelmaged A; El-Adawy AR; Eissa MK; Shaw RW
    Reprod Biol Endocrinol; 2013 Dec; 11():115. PubMed ID: 24341292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can AMH levels predict the need to step up FSH dose for controlled ovarian stimulation following a long GnRH agonist protocol in PCOS women?
    Huang H; Gao H; Shi Y; Deng B; He X; Lin J; Li P
    Reprod Biol Endocrinol; 2023 Dec; 21(1):121. PubMed ID: 38110998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation.
    Aghssa MM; Tarafdari AM; Tehraninejad ES; Ezzati M; Bagheri M; Panahi Z; Mahdavi S; Abbasi M
    Reprod Health; 2015 Sep; 12():85. PubMed ID: 26357853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study.
    Tshzmachyan R; Hambartsoumian E
    J Gynecol Obstet Hum Reprod; 2020 Feb; 49(2):101643. PubMed ID: 31563697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study.
    D'Amato G; Caringella AM; Stanziano A; Cantatore C; Palini S; Caroppo E
    Reprod Biol Endocrinol; 2018 Sep; 16(1):89. PubMed ID: 30217209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of repetitive oocyte retrieval on the ovarian reserve: a retrospective cohort study.
    Marschalek J; Ott J; Aitzetmueller M; Mayrhofer D; Weghofer A; Nouri K; Walch K
    Arch Gynecol Obstet; 2019 May; 299(5):1495-1500. PubMed ID: 30790103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
    Xi W; Yang Y; Mao H; Zhao X; Liu M; Fu S
    J Ovarian Res; 2016 Feb; 9():3. PubMed ID: 26864649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study.
    Li R; Gong F; Zhu Y; Fang W; Yang J; Liu J; Hu L; Yang D; Liang X; Qiao J
    Reprod Biomed Online; 2016 Oct; 33(4):506-512. PubMed ID: 27502068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
    El-Mazny A; Abou-Salem N
    Gynecol Endocrinol; 2013 Sep; 29(9):826-9. PubMed ID: 23855354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.